In focus · trending topic

WORLDSymposium 2016

2 stories · following the connections

BioMarin Announces Positive Data From Cerliponase Alfa Program for Treatment of CLN2 Disease, a Form of Batten Disease, at 12th Annual WORLDSymposium(TM) 2016

By Nasdaq OMXMar 3, 2016, 12:05 AM UTC

BioMarin Announces 21 Presentations at 12th Annual WORLDSymposium™ 2016 February 29-March 4 in San Diego, California: 6 Oral and 15 Poster

By Nasdaq OMXFeb 29, 2016, 1:25 PM UTC